Company intelligence / Profile preview

SagaNatura

Hafnarfjörður/Hafnarfjordur/Hafnarfjarðarkaupstaður, Icelandsaganatura.com ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

SagaNatura develops and commercializes natural health products derived from Icelandic botanicals such as Angelica archangelica and microalgae-derived astaxanthin. Their Angelica-based supplement has undergone preclinical studies and some clinical trials for overactive bladder. Astaxanthin products are marketed for antioxidant benefits with supporting scientific evidence of efficacy in reducing oxidative stress markers.

Therapeutic areas: OtherUrology
Modalities: Plant extractNatural compoundSmall molecule (for astaxanthin and plant-derived actives)Nutraceutical product
Industry: Food & Nutrition

Beyond the preview

Go deeper on SagaNatura.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SagaNatura.

Explore the full profile